Literature DB >> 16454709

Uracils as a cellular weapon against viruses and mechanisms of viral escape.

Stéphane Priet1, Joséphine Sire, Gilles Quérat.   

Abstract

Uracil in DNA is a deleterious event that may arise either by cytosine deamination or misincorporation of dUTP. Consequently, cells from all free-living organisms have developed strategies to protect their genome against the presence of uracils, by using uracil DNA glycosylase (UNG) and deoxyuridine triphosphatase (dUTPase) enzymatic activities. In the viral kingdom, some (namely poxviruses and herpesviruses) but not all of the DNA viruses encode their own UNG and dUTPase to control uracilation of their genome. Some retroviruses, which are RNA viruses using DNA as an intermediate of replication, also encode dUTPase. Surprisingly, though most of nonprimate lentiviruses encode dUTPase, primate lentiviruses such as HIV-1, HIV-2 or SIV do not. Because these latter viruses also replicate in nondividing cells where the dUTP/dTTP ratio is high, it is probable that they have found other ways to fight against the emergence of uracilated-viral transcripts. Indeed, recent studies showed that HIV-1 efficiently controls both the cytosine deamination and the dUTP misincorporation. The viral Vif protein acts in preventing the packaging into viral particles of the host-derived cytosine deaminase APOBEC3G enzyme, while the viral integrase domain of the Gag-Pol precursor mediates the packaging of the host-derived uracil DNA glycosylase UNG2 enzyme. In the absence of Vif or UNG2, HIV-1 viral transcripts are heavily charged in uracil bases leading to inactivation of the virus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16454709     DOI: 10.2174/157016206775197673

Source DB:  PubMed          Journal:  Curr HIV Res        ISSN: 1570-162X            Impact factor:   1.581


  15 in total

1.  GTP activator and dNTP substrates of HIV-1 restriction factor SAMHD1 generate a long-lived activated state.

Authors:  Erik C Hansen; Kyle J Seamon; Shannen L Cravens; James T Stivers
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

2.  Diverse fates of uracilated HIV-1 DNA during infection of myeloid lineage cells.

Authors:  Erik C Hansen; Monica Ransom; Jay R Hesselberth; Nina N Hosmane; Adam A Capoferri; Katherine M Bruner; Ross A Pollack; Hao Zhang; Michael Bradley Drummond; Janet M Siliciano; Robert Siliciano; James T Stivers
Journal:  Elife       Date:  2016-09-20       Impact factor: 8.140

3.  Uracil DNA glycosylase initiates degradation of HIV-1 cDNA containing misincorporated dUTP and prevents viral integration.

Authors:  Amy F Weil; Devlina Ghosh; Yan Zhou; Lauren Seiple; Moira A McMahon; Adam M Spivak; Robert F Siliciano; James T Stivers
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

4.  A new synthesis of S-aryl uracils from aryl thiols and 6-amino uracils in the presence of NCS.

Authors:  Gholamhossein Khalili
Journal:  Mol Divers       Date:  2016-07-05       Impact factor: 2.943

5.  Mimicking damaged DNA with a small molecule inhibitor of human UNG2.

Authors:  Daniel J Krosky; Mario A Bianchet; Lauren Seiple; Suhman Chung; L Mario Amzel; James T Stivers
Journal:  Nucleic Acids Res       Date:  2006-10-24       Impact factor: 16.971

Review 6.  Viruses with U-DNA: New Avenues for Biotechnology.

Authors:  Kinga K Nagy; Mikael Skurnik; Beáta G Vértessy
Journal:  Viruses       Date:  2021-05-10       Impact factor: 5.048

7.  Impact of linker strain and flexibility in the design of a fragment-based inhibitor.

Authors:  Suhman Chung; Jared B Parker; Mario Bianchet; L Mario Amzel; James T Stivers
Journal:  Nat Chem Biol       Date:  2009-04-26       Impact factor: 15.040

8.  Vaccinia virus lacking the deoxyuridine triphosphatase gene (F2L) replicates well in vitro and in vivo, but is hypersensitive to the antiviral drug (N)-methanocarbathymidine.

Authors:  Mark N Prichard; Earl R Kern; Debra C Quenelle; Kathy A Keith; Richard W Moyer; Peter C Turner
Journal:  Virol J       Date:  2008-03-05       Impact factor: 5.913

9.  Vif is a RNA chaperone that could temporally regulate RNA dimerization and the early steps of HIV-1 reverse transcription.

Authors:  S Henriet; L Sinck; G Bec; R J Gorelick; R Marquet; J-C Paillart
Journal:  Nucleic Acids Res       Date:  2007-07-26       Impact factor: 16.971

10.  Protein p56 from the Bacillus subtilis phage phi29 inhibits DNA-binding ability of uracil-DNA glycosylase.

Authors:  Gemma Serrano-Heras; José A Ruiz-Masó; Gloria del Solar; Manuel Espinosa; Alicia Bravo; Margarita Salas
Journal:  Nucleic Acids Res       Date:  2007-08-13       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.